🟢 Marker Therapeutics is trading 7.5% up on October 15, 2026 — no clear company-specific catalyst identified

Marker Therapeutics is trading at $0.96, up 7.52%, with no clear company-specific catalyst identified.

• Marker Therapeutics’ investor-relations page lists September 22, 2026, as its latest press release, about expanded manufacturing support from its CDMO partner.
• The supplied market snapshot is mixed: the Nasdaq is down 0.95% and the S&P 500 is down 0.32%; those figures do not explain the stock’s upward move.
• Volume information was not available.